We are live on ! Find out more
CA

Crewe Advisors Portfolio holdings

AUM $1.38B
1-Year Est. Return 41.76%
This Fund
S&P 500
This Quarter Est. Return
-2.18%
1 Year Est. Return
+41.76%
3 Year Est. Return
+96.1%
5 Year Est. Return
+98.15%
10 Year Est. Return
AUM
$712M
AUM Growth
-$13.7M
Cap. Flow
+$11.2M
Cap. Flow %
1.57%
Top 10 Hldgs %
60.79%
Holding
765
New
119
Increased
141
Reduced
110
Closed
49

Sector Composition

Rank Sector Weight
1 Financials 8.55%
2 Technology 4.36%
3 Healthcare 2.88%
4 Consumer Discretionary 2.35%
5 Energy 1.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FNDX icon
201
Schwab Fundamental US Large Company Index ETF
FNDX
$27.7B
$101K 0.01%
4,260
TIP icon
202
iShares TIPS Bond ETF
TIP
$15.1B
$100K 0.01%
902
DOMO icon
203
Domo
DOMO
$175M
$99.3K 0.01%
12,799
ARTY
204
iShares Future AI & Tech ETF
ARTY
$3.95B
$97.3K 0.01%
3,093
PNC icon
205
PNC Financial Services
PNC
$98.2B
$96.8K 0.01%
551
-47
-8% -$8.87K
RWK icon
206
Invesco S&P MidCap 400 Revenue ETF
RWK
$1.35B
$95K 0.01%
881
-160
-15% -$18.6K
ENB icon
207
Enbridge
ENB
$110B
$94K 0.01%
2,122
JAAA icon
208
Janus Henderson AAA CLO ETF
JAAA
$30B
$92.1K 0.01%
1,817
+475
+35% +$24.1K
MGM icon
209
MGM Resorts International
MGM
$10.9B
$92.1K 0.01%
3,107
TTE icon
210
TotalEnergies
TTE
$195B
$91K 0.01%
1,406
D icon
211
Dominion Energy
D
$58.9B
$90.2K 0.01%
1,608
DHR icon
212
Danaher
DHR
$152B
$86.9K 0.01%
424
+11
+3% +$2.4K
PXF icon
213
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$3B
$86.8K 0.01%
1,669
NVS icon
214
Novartis
NVS
$301B
$86.4K 0.01%
775
ADPT icon
215
Adaptive Biotechnologies
ADPT
$4.17B
$85.8K 0.01%
11,543
AFL icon
216
Aflac
AFL
$58.8B
$85.6K 0.01%
770
-335
-30% -$35.5K
SUSA icon
217
iShares ESG Optimized MSCI USA ETF
SUSA
$4.12B
$85.5K 0.01%
744
GD icon
218
General Dynamics
GD
$103B
$85.3K 0.01%
313
MO icon
219
Altria Group
MO
$115B
$84.6K 0.01%
1,410
AZZ icon
220
AZZ Inc
AZZ
$4.17B
$83.6K 0.01%
1,000
SYY icon
221
Sysco
SYY
$40.1B
$82.3K 0.01%
1,097
-88
-7% -$6.45K
BBAX icon
222
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
$6.89B
$80.4K 0.01%
1,653
DD icon
223
DuPont de Nemours
DD
$18.6B
$78.8K 0.01%
840
CTVA icon
224
Corteva
CTVA
$55.5B
$78.6K 0.01%
1,249
DFAT icon
225
Dimensional US Targeted Value ETF
DFAT
$14.6B
$77.8K 0.01%
+1,510
New +$83.1K

Similar funds

Crewe Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Crewe Advisors held 765 positions worth $712M, down 1.9% from $725M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Crewe Advisors's Q1 2025 filing shows 119 new, 141 increased, 110 reduced and 49 closed positions. Its largest new stake was Aspire Biopharma: 261 shares worth $183K. The largest sale was Berkshire Hathaway Class B, an estimated $6.93M.

By sector, the portfolio is most concentrated in Financials at 8.6% of assets, up from 8.3% a quarter earlier, followed by Technology and Healthcare.

  • Crewe Advisors's largest Q1 2025 buy was Aspire Biopharma: 261 shares worth $183K.
  • Crewe Advisors added most to iShares National Muni Bond ETF in Q1 2025, an estimated $9.71M increase.
  • Crewe Advisors's biggest Q1 2025 reduction was Berkshire Hathaway Class B, cutting an estimated $6.93M.
  • Crewe Advisors fully exited iShares 3-7 Year Treasury Bond ETF in Q1 2025, selling an estimated $754K.
  • Crewe Advisors's ten largest holdings make up 61% of its $712M portfolio in Q1 2025.
  • Crewe Advisors opened 119 new positions and closed 49 in Q1 2025.
  • Crewe Advisors's portfolio value fell 1.9% quarter-over-quarter to $712M.

Based on Crewe Advisors's 13F filing for Q1 2025, filed 23 Apr 2025.